Ikena Oncology, Inc.
Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the tran…
Biotechnology
US, Boston [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Ikena Oncology, Inc. has no acquisition track records yet.
M&A Deals · History
Ikena Oncology, Inc. has no acquisition track records yet.